x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
Blog

FDA’s September 2022 NPRMs: What They Mean for Academia and Industry

FDA’s new NPRMs would harmonize certain IRB regulations with the HHS Common Rule. Find out what this could mean for sites and sponsors.

Read Now
4 min. read
Read more
 
Podcast

My Favorite Case Study: Patient Centricity in Research

We discuss patient-centric strategies at CSL Behring to improve the patient experience and retention in clinical trials.

Listen Now
Read more
 
Blog

Modernizing Site Feasibility and Selection

An important decision impacting a multi-faceted study startup process is determining which sites to partner with for study conduct.

Read Now
5 min. read
Read more
 
Blog

Unpacking IRB Innovations for Decentralized Clinical Trials

Ethical oversight committees continue to innovate to keep pace with the rapid changes and evolution of research conduct.

Read Now
6 min. read
Read more
 
News

Advarra Achieves 1,000+ Site Milestone for its Gene Therapy Ready Network

Research involving gene therapy-based treatments can start more quickly with Advarra’s growing network of registered research sites.

Read Now
3 min. read
Read more
 
Blog

Strategies for Successful Site Selection in Clinical Trials

While clinical trial site selection aids in a trial’s success, it’s critical to maximize the study's time, resources, and funds.

Read Now
5 min. read
Read more
 
Blog

Keys to Unblocking the Innovation Bottleneck in Research

As the clinical trial industry has evolved in the past decade, it’s invited more complexity into operations and workflows.

Read Now
6 min. read
Read more
 
Webinar

Inspection Readiness: Before. During. After

This webinar will cover successful strategies for a proactive approach to FDA inspections before, during, and after.

Watch Now
Read more
 
Blog

How the IND 30-day Hold Impacts Clinical Trial Activities

Find out what research activities can and cannot be conducted during the Investigational New Drug (IND) 30-day hold period.

Read Now
6 min. read
Read more
 
Blog

Streamline Study Startup with Improved Site Selection & Feasibility

Identifying the best prepared and performing sites for a study is essential to success. Explore strategies to improve site selection and feasibility.

Read Now
5 min. read
Read more
 
Webinar

A Guide for Successful Cell and Gene Therapy Research

Understand the unique regulatory, clinical, and manufacturing requirements for cell and gene therapy research.

Watch Now
Read more
 
Webinar

Growth Mode: Developing a Fit-for-Purpose QMS Model

Learn successful strategies for a stepwise implementation of a clinical QMS, tailored to companies in growth mode.

Watch Now
Read more